We are live on ! Find out more
ACLS icon

Axcelis

385 hedge funds and large institutions have $3.37B invested in Axcelis in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 117 increasing their positions, 164 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $75.3M | Put options by funds: $47.7M

1.52% more ownership

Funds ownership: 91.08%92.61% (+1.5%)

8% less funds holding

Funds holding: 420385 (-35)

13% less capital invested

Capital invested by funds: $3.87B → $3.37B (-$499M)

29% less repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 164

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

37% less first-time investments, than exits

New positions opened: 59 | Existing positions closed: 93

Holders
385
Holders Change
-35
Holders Change %
-8.33%
% of All Funds
5.55%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
59
Increased
117
Reduced
164
Closed
93
Calls
$75.3M
Puts
$47.7M
Net Calls
+$27.6M
Net Calls Change
-$11.9M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$685M +$5.99M +50,233 +0.8%
Vanguard Group
2
Vanguard Group
Pennsylvania
$480M +$31.4M +263,604 +7%
State Street
3
State Street
Massachusetts
$136M +$2.46M +20,659 +2%
Primecap Management
4
Primecap Management
California
$113M -$3.46M -29,050 -3%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$89.8M +$3.37M +28,299 +4%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$75.5M -$1.75M -14,672 -2%
Morgan Stanley
7
Morgan Stanley
New York
$72.7M -$33.8M -283,471 -30%
Ameriprise
8
Ameriprise
Minnesota
$56.6M -$2.2M -18,478 -4%
JSP
9
Jackson Square Partners
California
$55M +$19.3M +162,040 +49%
Goldman Sachs
10
Goldman Sachs
New York
$53.7M +$4.67M +39,193 +9%
JP Morgan Chase
11
JP Morgan Chase
New York
$52M -$11.6M -97,494 -17%
T. Rowe Price Associates
12
T. Rowe Price Associates
Maryland
$51.6M -$46K -386 -0.1%
Norges Bank
13
Norges Bank
Norway
$50.6M +$1.61M +13,482 +3%
Charles Schwab
14
Charles Schwab
California
$49M +$1M +8,393 +2%
BNP Paribas Asset Management
15
BNP Paribas Asset Management
France
$47.2M +$14.1M +118,149 +39%
Millennium Management
16
Millennium Management
New York
$46.3M -$11.2M -94,295 -18%
Northern Trust
17
Northern Trust
Illinois
$41.1M -$883K -7,410 -2%
American Century Companies
18
American Century Companies
Missouri
$38.6M +$23.8M +199,833 +136%
RP
19
Reinhart Partners
Wisconsin
$37.9M +$40.5M +339,592 New
Voloridge Investment Management
20
Voloridge Investment Management
Florida
$37.8M +$30.2M +253,599 +298%
SM
21
Senvest Management
New York
$37.4M +$40M +335,814 New
PCMI
22
Paradigm Capital Management Inc
New York
$36.8M +$31.9M +267,800 +432%
Rafferty Asset Management
23
Rafferty Asset Management
New York
$32M +$9.96M +83,548 +41%
N
24
Nuveen
North Carolina
$31.2M -$10.6K -89 -0%
Grantham, Mayo, Van Otterloo & Co (GMO)
25
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$30.7M +$15.8M +132,415 +93%

ACLS Hedge Fund Activity: Q1 2024 in Review

385 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Axcelis (ACLS) for Q1 2024, worth a combined $3.37B — down 13% from $3.87B a quarter earlier.

Sellers outnumbered buyers: 93 funds closed out of ACLS and 59 opened new positions — a net loss of 34 holders — while 164 trimmed existing stakes and 117 added.

The largest buyer was Reinhart Partners, opening a new position worth an estimated $40.5M. The largest seller was Morgan Stanley, cutting an estimated $33.8M.

  • 385 institutional investors held Axcelis (ACLS) as of Q1 2024, down from 420 in Q4 2023.
  • Funds reported $3.37B of Axcelis stock for Q1 2024, down 13% quarter-over-quarter.
  • 59 funds opened new Axcelis positions in Q1 2024 and 93 closed out, a net change of -34 holders.
  • The largest Axcelis buyer in Q1 2024 was Reinhart Partners, an estimated $40.5M added.
  • The largest Axcelis seller in Q1 2024 was Morgan Stanley, an estimated $33.8M sold.

Based on aggregated 13F filings for Q1 2024.